{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,12,16]],"date-time":"2024-12-16T10:40:10Z","timestamp":1734345610599,"version":"3.30.2"},"reference-count":41,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,25]],"date-time":"2024-09-25T00:00:00Z","timestamp":1727222400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","advancesradonc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Advances in Radiation Oncology"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.adro.2024.101647","type":"journal-article","created":{"date-parts":[[2024,9,28]],"date-time":"2024-09-28T23:01:09Z","timestamp":1727564469000},"page":"101647","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Treatment Outcomes and Prognostic Factors of Chemotherapy Combined With Radiation Therapy for Patients With Early-Stage Extranodal Natural Killer\/T-Cell Lymphoma"],"prefix":"10.1016","volume":"9","author":[{"given":"Shu-Bei","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jia-Yi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei-Li","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheng","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei-Guo","family":"Cao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi-Min","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shu","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peng-Peng","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui-Juan","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8071-4422","authenticated-orcid":false,"given":"Gang","family":"Cai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.adro.2024.101647_bib0001","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s13045-019-0706-9","article-title":"Mortality of lymphoma and myeloma in China, 2004-2017: an observational study","volume":"12","author":"Liu","year":"2019","journal-title":"J Hematol Oncol"},{"key":"10.1016\/j.adro.2024.101647_bib0002","doi-asserted-by":"crossref","first-page":"4124","DOI":"10.1200\/JCO.2008.16.4558","article-title":"International peripheral T-cell and natural killer\/T-cell lymphoma study: Pathology findings and clinical outcomes","volume":"26","author":"Vose","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.adro.2024.101647_bib0003","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1182\/blood-2003-05-1401","article-title":"Primary nasal natural killer cell lymphoma: long-term treatment outcome and relationship with the International Prognostic Index","volume":"103","author":"Chim","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.adro.2024.101647_bib0004","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1016\/j.ijrobp.2013.12.005","article-title":"Immunophenotypic and clinical differences between the nasal and extranasal subtypes of upper aerodigestive tract natural killer\/T-cell lymphoma","volume":"88","author":"Liu","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.adro.2024.101647_bib0005","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1002\/ajh.25878","article-title":"Risk-based, response-adapted therapy for early-stage extranodal nasal-type NK\/T-cell lymphoma in the modern chemotherapy era: a China Lymphoma Collaborative Group study","volume":"95","author":"Qi","year":"2020","journal-title":"Am J Hematol"},{"key":"10.1016\/j.adro.2024.101647_bib0006","doi-asserted-by":"crossref","first-page":"3176","DOI":"10.1002\/cncr.30697","article-title":"The impact of the omission or inadequate dosing of radiotherapy in extranodal natural killer T-cell lymphoma, nasal type, in the United States","volume":"123","author":"Vargo","year":"2017","journal-title":"Cancer"},{"key":"10.1016\/j.adro.2024.101647_bib0007","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1001\/jamaoncol.2016.5094","article-title":"Association of improved locoregional control with prolonged survival in early-stage extranodal nasal-type natural killer\/T-cell lymphoma","volume":"3","author":"Yang","year":"2017","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.adro.2024.101647_bib0008","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2019.0194","article-title":"Risk-dependent conditional survival and failure hazard after radiotherapy for early-stage extranodal natural killer\/T-cell lymphoma","volume":"2","author":"Liu","year":"2019","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.adro.2024.101647_bib0009","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1182\/blood-2015-07-655191","article-title":"Nasal NK\/T-cell lymphoma: RT, CT, or both","volume":"126","author":"Tse","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.adro.2024.101647_bib0010","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1093\/annonc\/mdx684","article-title":"Sequential chemotherapy\/radiotherapy was comparable with concurrent chemoradiotherapy for stage I\/II NK\/T-cell lymphoma","volume":"29","author":"Kwong","year":"2018","journal-title":"Ann Oncol"},{"key":"10.1016\/j.adro.2024.101647_bib0011","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1007\/s00277-014-2244-4","article-title":"Early radiotherapy has an essential role for improving survival in patients with stage I-II nasal-type of NK\/T cell lymphoma treated with L-asparaginase-containing chemotherapy\u2013a single institution experience","volume":"94","author":"Zang","year":"2015","journal-title":"Ann Hematol"},{"key":"10.1016\/j.adro.2024.101647_bib0012","doi-asserted-by":"crossref","first-page":"2679","DOI":"10.1080\/10428194.2019.1599111","article-title":"Upfront radiation is essential for high-risk early-stage extranodal NK\/T-cell lymphoma, nasal type: Comparison of two sequential treatment modalities combining radiotherapy and GDP (gemcitabine, dexamethasone, and cisplatin) in the modern era","volume":"60","author":"Qi","year":"2019","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.adro.2024.101647_bib0013","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.leukres.2016.08.015","article-title":"Clinical impact of induction treatment modalities and optimal timing of radiotherapy for the treatment of limited-stage NK\/T cell lymphoma","volume":"49","author":"Moon","year":"2016","journal-title":"Leuk Res"},{"key":"10.1016\/j.adro.2024.101647_bib0014","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1080\/0284186X.2022.2044516","article-title":"A 10-year survival update on early-stage extranodal natural killer\/T-cell lymphoma with \u2018sandwich\u2019 therapy","volume":"61","author":"Yang","year":"2022","journal-title":"Acta Oncol"},{"key":"10.1016\/j.adro.2024.101647_bib0015","doi-asserted-by":"crossref","first-page":"3294","DOI":"10.1002\/cncr.26629","article-title":"Phase 2 trial of \u201csandwich\u201d L-asparaginase, vincristine, and prednisone chemotherapy with radiotherapy in newly diagnosed, stage IE to IIE, nasal type, extranodal natural killer\/T-cell lymphoma","volume":"118","author":"Jiang","year":"2012","journal-title":"Cancer"},{"key":"10.1016\/j.adro.2024.101647_bib0016","doi-asserted-by":"crossref","first-page":"3785","DOI":"10.1182\/blood-2005-05-2056","article-title":"Local tumor invasiveness is more predictive of survival than International Prognostic Index in stage I(E)\/II(E) extranodal NK\/T-cell lymphoma, nasal type","volume":"106","author":"Kim","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.adro.2024.101647_bib0017","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/S1470-2045(15)00533-1","article-title":"A prognostic index for natural killer cell lymphoma after non-anthracycline-based treatment: A multicentre, retrospective analysis","volume":"17","author":"Kim","year":"2016","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.adro.2024.101647_bib0018","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1038\/s41375-020-0791-3","article-title":"Validation of nomogram-revised risk index and comparison with other models for extranodal nasal-type NK\/T-cell lymphoma in the modern chemotherapy era: Indication for prognostication and clinical decision-making","volume":"35","author":"Chen","year":"2021","journal-title":"Leukemia"},{"key":"10.1016\/j.adro.2024.101647_bib0019","doi-asserted-by":"crossref","first-page":"2669","DOI":"10.1080\/10428194.2019.1602265","article-title":"Effect of primary tumor invasion on treatment and survival in extranodal nasal-type NK\/T-cell lymphoma in the modern chemotherapy era: A multicenter study from the China Lymphoma Collaborative Group (CLCG)","volume":"60","author":"Qi","year":"2019","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.adro.2024.101647_bib0020","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ijrobp.2015.01.009","article-title":"Modern radiation therapy for extranodal lymphomas: Field and dose guidelines from the International Lymphoma Radiation Oncology Group","volume":"92","author":"Yahalom","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.adro.2024.101647_bib0021","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1200\/JCO.2006.09.2403","article-title":"Revised response criteria for malignant lymphoma","volume":"25","author":"Cheson","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.adro.2024.101647_bib0022","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1200\/JCO.2005.04.1384","article-title":"Extranodal natural killer T-cell lymphoma, nasal-type: A prognostic model from a retrospective multicenter study","volume":"24","author":"Lee","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.adro.2024.101647_bib0023","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1097\/PAS.0b013e31826731b5","article-title":"Extranodal NK\/T-cell lymphoma, nasal type: A report of 73 cases at MD Anderson Cancer Center","volume":"37","author":"Li","year":"2013","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.adro.2024.101647_bib0024","doi-asserted-by":"crossref","first-page":"4061","DOI":"10.7314\/APJCP.2013.14.7.4061","article-title":"\u201cSandwich\u201d chemotherapy (CT) with radiotherapy (RT) improves outcomes in patients with stage IE\/IIE extranodal natural killer (NK)\/T-cell lymphomas","volume":"14","author":"Zhang","year":"2013","journal-title":"Asian Pac J Cancer Prev"},{"key":"10.1016\/j.adro.2024.101647_bib0025","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/s00277-012-1630-z","article-title":"Retrospective analysis of treatment outcomes for extranodal NK\/T-cell lymphoma (ENKL), nasal type, stage I-IIE: Single institute experience of combined modality treatment for early localized nasal extranodal NK\/T-cell lymphoma (ENKL)","volume":"92","author":"Lee","year":"2013","journal-title":"Ann Hematol"},{"key":"10.1016\/j.adro.2024.101647_bib0026","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/j.ijrobp.2011.02.039","article-title":"Mild toxicity and favorable prognosis of high-dose and extended involved-field intensity-modulated radiotherapy for patients with early-stage nasal NK\/T-cell lymphoma","volume":"82","author":"Wang","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.adro.2024.101647_bib0027","doi-asserted-by":"crossref","first-page":"274","DOI":"10.5045\/br.2013.48.4.274","article-title":"Sequential chemotherapy followed by radiotherapy versus concurrent chemoradiotherapy in patients with stage I\/II extranodal natural killer\/T-cell lymphoma, nasal type","volume":"48","author":"Lee","year":"2013","journal-title":"Blood Res"},{"key":"10.1016\/j.adro.2024.101647_bib0028","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.ijrobp.2015.07.2267","article-title":"Concurrent chemoradiation therapy followed by consolidation chemotherapy for localized extranodal natural killer\/T-cell lymphoma, nasal type","volume":"93","author":"Oh","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.adro.2024.101647_bib0029","doi-asserted-by":"crossref","first-page":"2973","DOI":"10.1182\/blood-2012-05-431460","article-title":"SMILE for natural killer\/T-cell lymphoma: Analysis of safety and efficacy from the Asia Lymphoma Study Group","volume":"120","author":"Kwong","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.adro.2024.101647_bib0030","doi-asserted-by":"crossref","first-page":"4771","DOI":"10.1182\/blood-2009-07-235853","article-title":"Primary radiotherapy showed favorable outcome in treating extranodal nasal-type NK\/T-cell lymphoma in children and adolescents","volume":"114","author":"Wang","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.adro.2024.101647_bib0031","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.ijrobp.2007.05.073","article-title":"Early or up-front radiotherapy improved survival of localized extranodal NK\/T-cell lymphoma, nasal-type in the upper aerodigestive tract","volume":"70","author":"Huang","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.adro.2024.101647_bib0032","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1007\/s00277-022-04892-x","article-title":"Comparison analysis of first-line asparaginase- versus non-asparaginase-based regimens for early-stage extranodal NK\/T-cell lymphoma","volume":"101","author":"Qi","year":"2022","journal-title":"Ann Hematol"},{"key":"10.1016\/j.adro.2024.101647_bib0033","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/1756-8722-5-27","article-title":"Complete remission after first-line radio-chemotherapy as predictor of survival in extranodal NK\/T cell lymphoma","volume":"5","author":"Chauchet","year":"2012","journal-title":"J Hematol Oncol"},{"key":"10.1016\/j.adro.2024.101647_bib0034","doi-asserted-by":"crossref","first-page":"8729","DOI":"10.18632\/aging.204355","article-title":"Deep remission from induction chemotherapy predicts favorable long-term survivals in early stage extranodal nasal NK\/T-cell lymphoma receiving sequential chemotherapy and radiation","volume":"14","author":"Qi","year":"2022","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.adro.2024.101647_bib0035","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1200\/JCO.2016.68.1619","article-title":"Treatments and outcomes of patients with extranodal natural killer\/T-cell lymphoma diagnosed between 2000 and 2013: A cooperative study in Japan","volume":"35","author":"Yamaguchi","year":"2017","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.adro.2024.101647_bib0036","doi-asserted-by":"crossref","first-page":"846","DOI":"10.3349\/ymj.2016.57.4.846","article-title":"The roles of radiotherapy and chemotherapy in the era of multimodal treatment for early-stage nasal-type extranodal natural killer\/T-cell lymphoma","volume":"57","author":"Kim","year":"2016","journal-title":"Yonsei Med J"},{"key":"10.1016\/j.adro.2024.101647_bib0037","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1093\/jrr\/rrw081","article-title":"Treatment outcomes of and prognostic factors for definitive radiotherapy with and without chemotherapy for stage I\/II nasal extranodal NK\/T-cell lymphoma","volume":"58","author":"Yang","year":"2017","journal-title":"J Radiat Res"},{"key":"10.1016\/j.adro.2024.101647_bib0038","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1600-0609.2007.00876.x","article-title":"Prognostic factors for classifying extranodal NK\/T cell lymphoma, nasal type, as lymphoid neoplasia","volume":"79","author":"Na","year":"2007","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.adro.2024.101647_bib0039","doi-asserted-by":"crossref","first-page":"700","DOI":"10.4149\/neo_2022_211004N1407","article-title":"Does the primary tumor site in stage I extranodal natural killer\/T-cell lymphoma matter?","volume":"69","author":"Cui","year":"2022","journal-title":"Neoplasma"},{"key":"10.1016\/j.adro.2024.101647_bib0040","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1093\/annonc\/mdm183","article-title":"Ki-67 expression is predictive of prognosis in patients with stage I\/II extranodal NK\/T-cell lymphoma, nasal type","volume":"18","author":"Kim","year":"2007","journal-title":"Ann Oncol"},{"key":"10.1016\/j.adro.2024.101647_bib0041","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1016\/j.ijrobp.2021.02.011","article-title":"Modern radiation therapy for extranodal nasal-type NK\/T-cell lymphoma: Risk-adapted therapy, target volume, and dose guidelines from the International Lymphoma Radiation Oncology Group","volume":"110","author":"Qi","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["Advances in Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452109424002100?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452109424002100?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,16]],"date-time":"2024-12-16T09:34:56Z","timestamp":1734341696000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2452109424002100"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":41,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["S2452109424002100"],"URL":"https:\/\/doi.org\/10.1016\/j.adro.2024.101647","relation":{},"ISSN":["2452-1094"],"issn-type":[{"type":"print","value":"2452-1094"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment Outcomes and Prognostic Factors of Chemotherapy Combined With Radiation Therapy for Patients With Early-Stage Extranodal Natural Killer\/T-Cell Lymphoma","name":"articletitle","label":"Article Title"},{"value":"Advances in Radiation Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.adro.2024.101647","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc. on behalf of American Society for Radiation Oncology.","name":"copyright","label":"Copyright"}],"article-number":"101647"}}